Key result
Higher extracellular volume assessed via CMR T1 mapping was associated with an increased risk of death and/or heart failure hospitalization in patients with HFpEF (HR 1.12; 95% CI 1.06-1.18; p<0.0001).
Why the study?
The study was conducted to evaluate the prognostic value of cardiac magnetic resonance T1 mapping techniques in patients with heart failure with preserved ejection fraction.
Does higher extracellular volume (ECV) assessed via CMR T1 mapping predict the risk of death and/or hospitalization in patients with HFpEF?
Meta-Analysis (n=1,930)
Does higher extracellular volume (ECV) assessed via CMR T1 mapping predict the risk of death and/or hospitalization in patients with HFpEF?
Hazard Ratio: 1.12 (95% CI 1.06–1.18)
p-value: p=< 0.0001
Assessment of extracellular volume via CMR T1 mapping provides significant prognostic value for predicting death or heart failure hospitalization in patients with HFpEF.
May enhance HFpEF risk stratification; reinforces CMR T1 mapping prognostic value in meta-analysis.
Objectives: Our study aimed at conducting a systematic review and meta-analysis, with the objective of evaluating the prognostic value of T1 mapping techniques via cardiac magnetic resonance (CMR) in heart failure with preserved ejection fraction (HFpEF) patients. Materials and methods: The protocol was prospectively registered in the international prospective register of systematic reviews PROSPERO (registration number CRD42022300991). We searched PubMed, Google Scholar, and EMBASE for studies examining the prognostic value of characterizing myocardial tissue via CMR imaging with T1 mapping in HFpEF. Hazard ratios (HRs) for uniformly defined predictors were pooled for meta-analysis. Results: In total, 7 studies were retrieved from 351 publications for this systematic review and meta-analysis. A total of 1930 patients (mean age of 69.4 years, mean follow-up duration of 25.6 months) was included in the analysis. The meta-analysis demonstrated that higher extracellular volume (ECV) was associated with an increased risk of death and/or hospitalization with heart failure (HF) (HR:1.12; 95% CI: 1.06−1.18; p < 0.0001). After adjusting for baseline characteristics, the higher extent of ECV remained strongly associated with the risk of death and/or hospitalization with HF (HRadjusted: 1.08; 95% CI: 1.04−1.13; p = 0.0001). However, no significant association of native T1 value with risk of death or adverse cardiovascular events was found (HR:1.01; 95% CI: 1.00−1.02; p = 0.21). Conclusion: Assessment of ECV via CMR has an important prognostic value for outcomes of death and/or hospitalization with HF, and can therefore be used as an effective tool for risk stratification of patients with HFpEF.
No takes yet. Share an insight, caveat, or question.
Голухова et al. (2022) conducted a meta-analysis in heart failure with preserved ejection fraction (HFpEF) (n=1,930). Higher extracellular volume (ECV) via CMR T1 mapping was evaluated on death and/or hospitalization with heart failure (HF) (HR 1.12, 95% CI 1.06-1.18, p=< 0.0001). Higher extracellular volume assessed via CMR T1 mapping was associated with an increased risk of death and/or heart failure hospitalization in patients with HFpEF (HR 1.12; 95% CI 1.06-1.18; p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: